Showing posts with label menopause. Show all posts
Showing posts with label menopause. Show all posts
Wednesday, December 12, 2018

Menopausal transition period is a "critical window" for cardiovascular prevention in women

›
A healthy lifestyle during the perimenopausal and menopausal years reduces the risk of cardiovascular events in later life report the ...
5 comments:
Sunday, October 7, 2018

News from NAMS 2018: Estetrol, the next generation hormone therapy linked to significant improvement in menopausal VMS

›
Estetrol (E4) (Donesta®) in daily oral dose of 15 mg appears to be the most effective dose for the treatment of menopausal VMS report...
1 comment:
Wednesday, October 3, 2018

NAMS 2018 annual meeting kicks off in San Diego, California

›
The North American Menopause Society Annual Scientific Meeting kicks off today in San Diego, California. The agenda is packed with symp...
1 comment:
Tuesday, September 25, 2018

North American Menopause Society (NAMS) video series about important midlife health topics: What women need to know about stress?

›
The North American Menopause Society (NAMS) provides practical information on important midlife health topics for women. All the interview...
1 comment:
Wednesday, August 29, 2018

North American Menopause Society (NAMS) video series about important midlife health topics: Nonhormone Prescription Options for Hot Flashes

›
The North American Menopause Society (NAMS) provides practical information on important midlife health topics for women. All the interview...
3 comments:
Wednesday, July 25, 2018

Vaginal dryness— why no one is talking or doing anything about it?

›
A new study published in the North American Menopause Society's Journal Menopause identifies the factors associated with the tabo...
1 comment:
Thursday, June 14, 2018

What should midlife women know about preventive cardiology?

›
We are all aware that sex and gender differences are important in the diagnosis and management of cardiovascular diseases. A woman’s risk o...
3 comments:
Wednesday, June 6, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

›
The United States Food and Drug Administration (FDA) has approved TX-004HR: IMVEXXY (estradiol vaginal inserts) for the treatment of...
3 comments:
Tuesday, March 20, 2018

New oral drug treatment found highly effective in reducing menopausal hot flashes

›
A neurokinin 3 receptor (NK3R) antagonist (MLE4901) rapidly reduced hot flashes for short and long-term in postmenopausal women; thus,...
36 comments:
Sunday, February 4, 2018

Younger age at hysterectomy linked to increased risk of heart disease later in life

›
Ovarian conservation at hysterectomy does not reduce the risk of future cardiometabolic diseases reports the results of large prospe...
Saturday, February 3, 2018

A practical guide to count ovarian antral follicles by ultrasound

›
A consensus opinion highlighting the main techniques of ovarian antral follicle count (AFC), and providing recommendations for future re...
2 comments:
Wednesday, October 11, 2017

NAMS updates position statement about Hormone Therapy at the 2017 annual meeting

›
courtesy: dailytimes.com The North American Menopause Society(NAMS) executive director, JoAnn Pinkerton, MD, from the University of ...
Tuesday, September 26, 2017

On World Contraceptive day: Review of contraception during perimenopausal years.

›
September 26 th  is  World Contraceptive day, it is annual worldwide campaign to improve global awareness about contraception, with th...
1 comment:
Friday, July 7, 2017

NAMS updates its position statement on HRT, clearing five critical areas of confusion.

›
courtesy: www.renewedvitalitymd.com The North American Menopause Society has updated its position statement regarding menopausal an...
Wednesday, April 12, 2017

New class of drug effective in targeting menopausal symptoms: News from Endocrine Conference 2017.

›
courtesy: Getty images A new class of drug Neurokinin 3 (NK3) receptor antagonists is highly effective and low risk alternative to h...
2 comments: